Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Ju-Yeun LEE; Yul-Hee KIM; Nam-Joon YI; Hyang-Sook KIM; Hye-Suk LEE; Byung-Koo LEE; Hyeyoung KIM; Young-Rok CHOI; Geun HONG; Kwang-Woong LEE; Kyung-Suk SUH.
Clinical and Molecular Hepatology ; : 192-203, 2014.
Artículo en Inglés | WPRIM | ID: wpr-119484

Documentos relacionados

  1. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation.
  2. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation.
  3. Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.
  4. Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin.
  5. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
  6. Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma.
  7. Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
  8. [Tumor markers for hepatocellular carcinoma].
  9. Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.
  10. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.